nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Clinical and molecular features of platinum resistance in ovarian cancer
|
Miras, Isabel |
|
|
201 |
C |
p. |
artikel |
2 |
Editorial Board
|
|
|
|
201 |
C |
p. |
artikel |
3 |
Evolving cancer resistance to anti-PD-1/PD-L1 antibodies in melanoma: Comprehensive insights with future prospects
|
Li, Wenyu |
|
|
201 |
C |
p. |
artikel |
4 |
Expanding horizons in cancer therapy by immunoconjugates targeting tumor microenvironments
|
Fattahi, Amir Saamaan |
|
|
201 |
C |
p. |
artikel |
5 |
Faecal immunochemical tests can improve colonoscopy triage in patients with iron deficiency: A systematic review and meta-analysis
|
Pham, Jennifer |
|
|
201 |
C |
p. |
artikel |
6 |
From theory to practice: Implementing next-generation sequencing and public health genomics in healthcare systems
|
Horgan, Denis |
|
|
201 |
C |
p. |
artikel |
7 |
Health-related quality of life with comprehensive geriatric assessment guided care versus usual care in older adults with cancer: A systematic review and meta-analysis of randomized trials
|
Ng, Zhi Xuan |
|
|
201 |
C |
p. |
artikel |
8 |
Heterogeneous pathogenesis of melanoma: BRAF mutations and beyond
|
Colombino, Maria |
|
|
201 |
C |
p. |
artikel |
9 |
Identifying causes of balance impairment and exploring sensory contributions to balance in pediatric oncology: A scoping review
|
McCarthy, Emily |
|
|
201 |
C |
p. |
artikel |
10 |
Integrating nutrition, physical exercise, psychosocial support and antiemetic drugs into CINV management: The road to success
|
Belluomini, Lorenzo |
|
|
201 |
C |
p. |
artikel |
11 |
Management of bone disease with concurrent chimeric antigen receptor T-cell therapy for multiple myeloma
|
Kuruvilla, Davis |
|
|
201 |
C |
p. |
artikel |
12 |
Metabolic vulnerabilities in cancer: A new therapeutic strategy
|
El-Tanani, Mohamed |
|
|
201 |
C |
p. |
artikel |
13 |
Multigenic panels in breast cancer: Clinical utility and management of patients with pathogenic variants other than BRCA1/2
|
Fabi, Alessandra |
|
|
201 |
C |
p. |
artikel |
14 |
Needs of breast cancer survivors: a systematic review of quantitative data
|
Paltrinieri, S. |
|
|
201 |
C |
p. |
artikel |
15 |
Next-generation biomarkers for prognostic and potential therapeutic enhancement in Triple negative breast cancer
|
Banerjee, Risav |
|
|
201 |
C |
p. |
artikel |
16 |
Role of hematological and neurological expressed 1 (HN1) in human cancers
|
Li, Huangcan |
|
|
201 |
C |
p. |
artikel |
17 |
Safety and efficacy of liposomal irinotecan as the second-line treatment for advanced pancreatic cancer: A systematic review and meta-analysis
|
Chen, Brian Shiian |
|
|
201 |
C |
p. |
artikel |
18 |
Safety profile of first-line targeted therapies in elderly and/or comorbid chronic lymphocytic leukaemia patients (unfit subpopulation). A systematic review and network meta-analysis
|
Stożek-Tutro, Anita |
|
|
201 |
C |
p. |
artikel |
19 |
Severe infections in patients with chronic lymphocytic leukemia included in trials investigating BTK and BCL2 inhibitors
|
Mauro, Francesca R. |
|
|
201 |
C |
p. |
artikel |
20 |
Standardized molecular pathology workflow for ctDNA-based ESR1 testing in HR+/HER2- metastatic breast cancer
|
Guerini-Rocco, Elena |
|
|
201 |
C |
p. |
artikel |
21 |
Surrogate endpoints in phase III randomized trials of advanced gastroesophageal cancer: A systematic review and meta-analysis
|
Veas Rodríguez, Joel |
|
|
201 |
C |
p. |
artikel |
22 |
Understanding mechanisms of resistance to FLT3 inhibitors in adult FLT3-mutated acute myeloid leukemia to guide treatment strategy
|
Ruglioni, Martina |
|
|
201 |
C |
p. |
artikel |